Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Chrolavicius

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
European Heart Journal|December 18, 2007
Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatmentJonas Oldgren, Lars Wallentin, Rizwan Afzal, et al.
American Heart Journal|February 15, 2011
Design and rationale of the radial versus femoral access for coronary intervention (RIVAL) trial: a randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromesSanjit S Jolly, Kari Niemelä, Denis Xavier, et al.
Journal of the American College of Cardiology|October 30, 2007
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trialShamir R Mehta, Christopher B Granger, John W Eikelboom, et al.
American Heart Journal|March 3, 2009
Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of riskCampbell D Joyner, Ron J G Peters, Rizwan Afzal, et al.
European Heart Journal|August 21, 2008
Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromesAndrzej Budaj, John W Eikelboom, Shamir R Mehta, et al.
The New England Journal of Medicine|September 8, 2010
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes, Shamir R Mehta, Jean-Pierre Bassand, et al.
Journal of the American College of Cardiology|July 25, 2009
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trialSanjit S Jolly, David P Faxon, Keith A A Fox, et al.
Lancet (London, England)|April 8, 2011
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trialSanjit S Jolly, Salim Yusuf, John Cairns, et al.
JAMA|September 1, 2010
Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial, Philippe Gabriel Steg, Sanjit S Jolly, et al.
Lancet (London, England)|May 16, 2008
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial, P J Devereaux, Homer Yang, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
European Heart Journal|December 18, 2007
Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatmentJonas Oldgren, Lars Wallentin, Rizwan Afzal, et al.
American Heart Journal|February 15, 2011
Design and rationale of the radial versus femoral access for coronary intervention (RIVAL) trial: a randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromesSanjit S Jolly, Kari Niemelä, Denis Xavier, et al.
Journal of the American College of Cardiology|October 30, 2007
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trialShamir R Mehta, Christopher B Granger, John W Eikelboom, et al.
American Heart Journal|March 3, 2009
Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of riskCampbell D Joyner, Ron J G Peters, Rizwan Afzal, et al.
European Heart Journal|August 21, 2008
Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromesAndrzej Budaj, John W Eikelboom, Shamir R Mehta, et al.
The New England Journal of Medicine|September 8, 2010
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes, Shamir R Mehta, Jean-Pierre Bassand, et al.
Journal of the American College of Cardiology|July 25, 2009
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trialSanjit S Jolly, David P Faxon, Keith A A Fox, et al.
Lancet (London, England)|April 8, 2011
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trialSanjit S Jolly, Salim Yusuf, John Cairns, et al.
JAMA|September 1, 2010
Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial, Philippe Gabriel Steg, Sanjit S Jolly, et al.
Lancet (London, England)|May 16, 2008
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial, P J Devereaux, Homer Yang, et al.
Pageof 4